Preliminary scientific tests reveal conolidine may inhibit distinct ion channels, reducing neuronal excitability and restricting agony indicators. This mechanism is particularly appropriate in neuropathic agony, where irregular signaling causes persistent soreness. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pa